The CCPC project is designed to enable patients to continue their care at home following discharge through the development of new predictive analytics, AI, and home monitoring technology
Artificial intelligence (AI) startup FluidAI Medical has forged a collaboration with Medtronic’s subsidiary in Canada for remote patient monitoring through the Continuous Connected Patient Care (CCPC) project to transform the Canadian healthcare system.
The CCPC project comes under the Canada’s Global Innovation Cluster for digital technologies, called as DIGITAL, which is providing C$5.2m ($3.85m) of co-investment to the project.
According to FluidAI Medical, the CCPC project is designed to enable patients to continue their care at home following discharge. It develops new predictive analytics, AI, and home monitoring technology that connects with existing medical systems for continuous care from hospital to home,
The project will be led by Medtronic in partnership with a consortium of Canadian healthcare and technology organisations.
The partners include Cloud DX, Excelar Technologies, Providence Health Care’s St. Paul’s Hospital, Providence Health Care (PHC) Ventures, Simon Fraser University (SFU), Bridge Health Solutions (BHS), StarFish Medical, and now Canada-based FluidAI to build the integrated monitoring system.
Medtronic open innovation and R&T R&D director Rick Sethi said: “As healthcare delivery and patient needs change, it is important that we continue to evolve how we and our partners provide tools and support for our clinicians.
“Collaboration is key to develop new patient-centric solutions and augment our clinicians with personalised care for their patients.”
Under the partnership, Medtronic will assess new technologies and use an advanced clinical-grade medical device. FluidAI Medical will improve its current platform offering to allow at-home patient use.
This will allow the startup to work together with the Medtronic device and build a cloud platform to enable use of their platform in a remote patient monitoring environment and integrate with the consortium partner offerings, FluidAI Medical said.
Bridge Health Solutions will upgrade its medication dispensing, tracking, and adherence monitoring solution whereas Excelar will enhance its clinical data normalisation module.
Providence Health Care and PHC Ventures will provide workflow, needs, patient and clinical requirements and will work on the final design and development of the solution.
The staff from Providence Health Care’s St. Paul’s Hospital and Hamilton Health Sciences will handle the clinical trials of the monitoring system whereas Simon Fraser University has agreed to collect feedback on user needs to direct the development of the technology, clinical decision support system, and user interfaces.
Furthermore, Cloud DX will offer a secure, ISO-certified solution with advanced capabilities to securely monitor patients.